The Sasakawa Leprosy Initiative hosted the 3rd Global Forum of People’s Organizations on Hansen’s Disease from July 4 to 6, 2025, in Bali, Indonesia.

This international forum brought together persons affected by Hansen’s disease, their representative organizations, and global stakeholders to discuss shared challenges, promote human rights, and advance efforts to eliminate stigma and discrimination.

We are pleased to announce that recordings of the public sessions are now available for on-demand viewing. If you were unable to join us live, please watch the sessions below.

Live-Streamed Session

Day 2 – Saturday, July 5 (09:00 – 12:45（WITA）：UTC+8 )

0:00:00 Formal Opening Session

• 0:02:30 Mr. Al Kadri – Chairman, PerMaTa Indonesia
• 0:11:40 Mr. Brent Morgan – International Director, The Leprosy Mission International
• 0:15:38 Mr. Peter Whadupp – CEO, The Leprosy Mission Great Britain
• 0:22:20 Mr. Geoff Warne – CEO, International Federation of Anti-Leprosy Associations
• 0:30:55 Dr. Beatriz Miranda – United Nations Special Rapporteur on the elimination of discrimination against persons affected by leprosy and their family members
• 0:44:32 Dr. Takahiro Nanri – President, Sasakawa Health Foundation

0:54:00 Presentation: Success Stories from Global Coalitions and National-Level Impact Strategies 

　　– Dr. Neeraj Mistry, Deputy Director, Future Africa Institute, University of Pretoria; Member, Global Health EDCTP3 Joint Undertaking

　　1:31:22 Q&A – Success Stories and Impact Strategies

1:35:24 Presentation: Evidence-Based Advocacy and High-Level Lobbying Strategies 

　　– Dr. Krishna Man Pradhan and Mr. Mohan Acharya, Nepal Law Society

　　1:53:41 Q&A – Advocacy Strategies

1:58:11 Panel Presentations: Resource Mobilization Experiences from People’s and Civil Society Organizations

• 2:02:01 Mr. Wu Yaoqiang and Ms. Sally Qi – HANDA, China
• 2:15:51 Reverend Joshua Sivagnanam – Kaveri Kala Manram / Leprosy People Association – Sri Lanka
• 2:36:08 Dr. Shayla Islam – BRAC, Bangladesh
• 3:00:57 Q&A – Resource Mobilization

Day 3 – Sunday, July 6 (09:00 – 17:00 （WITA）：UTC+8)

0:00:00 Group Presentations by Participants

0:56:00 Presentation of Draft Key Outputs by Drafting Committee – Followed by Plenary Discussion Facilitated by Group Moderators

2:31:07 Conclusions and Next Steps – Including Plans for the Next Global Forum

Roundtable between representatives of persons with lived experience and stakeholders

• 2:36:29 Introduction of Stakeholders: WHOGLP, ILEP, UN Special Rapporteur, Ministry of Health Indonesia, ILC, ILA, Novartis, GPZL*
• 2:44:00 Summary of the Three Key Outputs
• 3:06:14 Q&A: Stakeholder Responses to People’s Organizations on Dissemination, Input, and Contribution to the Key Outputs
• 4:08:48 Q&A

4:58:34 Keynote Speech – Mr. Yohei Sasakawa, WHO Goodwill Ambassador for Leprosy Elimination

5:39:29 Closing Remarks – Ms. Binti Khofifah, S.K.M, Epid., PerMaTa Indonesia

*Note
WHOGLP –Dr. Vivek Lal, Team Leader, Global Leprosy Programme, World Health Organization
ILEP – Mr. Brent Morgan, President, International Federation of Anti-Leprosy Associations
UN Special Rapporteur – Dr. Beatriz Miranda, United Nations Special Rapporteur on the elimination of discrimination against persons affected by leprosy and their family members
MoH Indonesia – Dr. Regina Tiolina Sidjabat, Head, Neglected Tropical Diseases (NTD) Task Force, Ministry of Heath of Indonesia
ILC – Dr. M. Yulianto Listiawan, Chairman, International Leprosy Congress 2025
ILA – Dr. P Narasimha Rao, President, International Leprosy Association
Novartis – Dr. Sunil Modali, Novartis Foundation
GPZL – Dr. Ritu Ghosh, Executive Director, Global Partnership for Zero Leprosy